TR200101040T2 - ß-alanin türevi üretmek için yeni işlemler - Google Patents
ß-alanin türevi üretmek için yeni işlemlerInfo
- Publication number
- TR200101040T2 TR200101040T2 TR2001/01040T TR200101040T TR200101040T2 TR 200101040 T2 TR200101040 T2 TR 200101040T2 TR 2001/01040 T TR2001/01040 T TR 2001/01040T TR 200101040 T TR200101040 T TR 200101040T TR 200101040 T2 TR200101040 T2 TR 200101040T2
- Authority
- TR
- Turkey
- Prior art keywords
- produce
- new processes
- alanine derivative
- salt
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Mevcut bulus, formül (I) ile gösterilen -alanin türevi hazirlamak için islemlerle ilgilidir; burada R1 amino koruyucu gruptur ve R2 asil grubudur ya da onun bir tuzudur, islem formül (II)'nin bir bilesiminin; burada R1 yukarida tanimlandigi gibidir ve R3 korunmus karboksidir ya da onun bir tuzudur, karboksi koruma grubu ile ortadan kaldirma reaksiyonuna tabi tutulmasini ve sonra amino grubunun asilasyon lreaksiyonuna tabi tutulmasini içerir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP6465A AUPP646598A0 (en) | 1998-10-12 | 1998-10-12 | New processes for producing alpha-alanine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200101040T2 true TR200101040T2 (tr) | 2001-08-21 |
Family
ID=3810687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/01040T TR200101040T2 (tr) | 1998-10-12 | 1999-10-07 | ß-alanin türevi üretmek için yeni işlemler |
Country Status (16)
Country | Link |
---|---|
US (2) | US6538007B1 (tr) |
EP (1) | EP1121346A1 (tr) |
JP (1) | JP2002527424A (tr) |
KR (1) | KR20010075623A (tr) |
CN (1) | CN1329595A (tr) |
AR (1) | AR020768A1 (tr) |
AU (1) | AUPP646598A0 (tr) |
BR (1) | BR9914780A (tr) |
CA (1) | CA2346433A1 (tr) |
CZ (1) | CZ20011324A3 (tr) |
HK (1) | HK1043120A1 (tr) |
HU (1) | HUP0104067A3 (tr) |
TR (1) | TR200101040T2 (tr) |
TW (1) | TW490460B (tr) |
WO (1) | WO2000021932A1 (tr) |
ZA (1) | ZA200102781B (tr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010051730A1 (en) * | 1993-09-22 | 2001-12-13 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivative and a process for the preparation thereof |
AUPQ570100A0 (en) * | 2000-02-17 | 2000-03-09 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivatives and their use as receptor antagonists |
US20050107350A1 (en) * | 2003-08-22 | 2005-05-19 | Pharmacia Corporation | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
WO2005079863A1 (ja) | 2004-02-25 | 2005-09-01 | Astellas Pharma Inc. | 血栓造影剤 |
CN105017134A (zh) * | 2015-07-26 | 2015-11-04 | 陈吉美 | 一种4-吡啶丙烯酸的制备方法 |
JP7220653B2 (ja) | 2016-11-08 | 2023-02-10 | ブリストル-マイヤーズ スクイブ カンパニー | アルファvインテグリン阻害剤としてのピロールアミド |
CN110078657A (zh) * | 2019-04-10 | 2019-08-02 | 湖州复华春生物医药科技有限公司 | 一种手性3-氨基哌啶及其衍生物的合成方法 |
CN109970585A (zh) * | 2019-04-29 | 2019-07-05 | 安徽安力肽生物科技有限公司 | 一种β-丙氨酸酯类化合物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2161155C2 (ru) * | 1993-09-22 | 2000-12-27 | Фудзисава Фармасьютикал Ко., Лтд | Производные n-(3-пиперидинилкарбонил)-бета-аланина в качестве антагонистов фактора активации тромбоцитов (фат), способ получения, фармацевтическая композиция и способ лечения |
CA2215106A1 (en) | 1995-03-17 | 1996-09-26 | Fujisawa Pharmaceutical Co., Ltd. | N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors |
WO1997033869A1 (en) * | 1996-03-13 | 1997-09-18 | Fujisawa Pharmaceutical Co., Ltd. | N-[(r)-1-{3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
-
1998
- 1998-10-12 AU AUPP6465A patent/AUPP646598A0/en not_active Abandoned
-
1999
- 1999-10-04 TW TW088117056A patent/TW490460B/zh not_active IP Right Cessation
- 1999-10-07 HU HU0104067A patent/HUP0104067A3/hu unknown
- 1999-10-07 TR TR2001/01040T patent/TR200101040T2/tr unknown
- 1999-10-07 CZ CZ20011324A patent/CZ20011324A3/cs unknown
- 1999-10-07 US US09/806,483 patent/US6538007B1/en not_active Expired - Fee Related
- 1999-10-07 KR KR1020017004562A patent/KR20010075623A/ko not_active Application Discontinuation
- 1999-10-07 CA CA002346433A patent/CA2346433A1/en not_active Abandoned
- 1999-10-07 JP JP2000575841A patent/JP2002527424A/ja not_active Withdrawn
- 1999-10-07 EP EP99970380A patent/EP1121346A1/en not_active Withdrawn
- 1999-10-07 BR BR9914780-7A patent/BR9914780A/pt not_active Application Discontinuation
- 1999-10-07 WO PCT/JP1999/005520 patent/WO2000021932A1/en active IP Right Grant
- 1999-10-07 CN CN99814265A patent/CN1329595A/zh active Pending
- 1999-10-08 AR ARP990105130A patent/AR020768A1/es unknown
-
2001
- 2001-04-04 ZA ZA200102781A patent/ZA200102781B/en unknown
-
2002
- 2002-06-19 HK HK02104562.8A patent/HK1043120A1/zh unknown
- 2002-12-13 US US10/318,087 patent/US20030114488A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR020768A1 (es) | 2002-05-29 |
TW490460B (en) | 2002-06-11 |
BR9914780A (pt) | 2001-10-30 |
CA2346433A1 (en) | 2000-04-20 |
AUPP646598A0 (en) | 1998-11-05 |
EP1121346A1 (en) | 2001-08-08 |
ZA200102781B (en) | 2002-07-04 |
JP2002527424A (ja) | 2002-08-27 |
HK1043120A1 (zh) | 2002-09-06 |
HUP0104067A2 (hu) | 2002-03-28 |
KR20010075623A (ko) | 2001-08-09 |
CN1329595A (zh) | 2002-01-02 |
US6538007B1 (en) | 2003-03-25 |
CZ20011324A3 (cs) | 2001-08-15 |
WO2000021932A1 (en) | 2000-04-20 |
HUP0104067A3 (en) | 2002-04-29 |
US20030114488A1 (en) | 2003-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102957T2 (tr) | Sitalopram hazırlanması için metod. | |
TW360990B (en) | Electroconversion cell | |
PL341044A1 (en) | Derivatives of orthoantranilic amide as anticoagulants | |
PE43597A1 (es) | Procedimiento y derivados de n-(3-benzofuranil)urea | |
GB9803226D0 (en) | Chemical compounds | |
IE801713L (en) | N-(3-mercapto-2-alkyl-1-oxopropyl)-2,¹3-dihydro-1h-indole-2-carboxylic acids | |
HUP9802859A2 (hu) | Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként | |
PT804200E (pt) | Uso de derivados de noribogaina para tratamento de dependencia quimica em mamiferos | |
TR199901874T2 (tr) | 3'-n-oksit,3'-n-dimetilamin, 9-oksim eritromisin A türevleri. | |
PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
ID21450A (id) | S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon | |
TR200101040T2 (tr) | ß-alanin türevi üretmek için yeni işlemler | |
PT991651E (pt) | Intermediarios de carbapenem estabilizados e uso sintetico | |
WO2000042995A3 (en) | Use of anticonvulsant derivatives for treating transformed migraine | |
AU2274999A (en) | 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents | |
TR200000117T2 (tr) | Alkiloksifuranonun aminli türevlerinin hazırlanmasına yönelik proses. | |
ES8607967A1 (es) | Un procedimiento para la preparacion de nuevos derivados delacido tiazolilacetico | |
ATE258782T1 (de) | Mittel und verfahren zur färbung von fasern | |
TR200002804T2 (tr) | MRP1 inhibe etmek için yöntemler | |
ES2131015A1 (es) | Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas. | |
TR199700481A2 (tr) | Sefem ve izooksafem türevlerinin hazirlanmasi. | |
DK0779895T3 (da) | Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider | |
TR199901474T2 (tr) | Imisazol türevleri için proses. | |
TW342416B (en) | Treating agent for synthetic fiber | |
PT971899E (pt) | Compostos de hexa-hidroindenopiridina possuindo actividade antiespermatogenica. |